Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, anabasum, is a novel synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. It is currently being evaluated in four clinical programs: systemic sclerosis, cystic fibrosis, dermatomyositis and systemic lupus erythematosus.

Norwood, US
Size (employees)
25 (est)
Corbus Pharmaceuticals was founded in 2009 and is headquartered in Norwood, US
Report incorrect company information

Corbus Pharmaceuticals Office Locations

Corbus Pharmaceuticals has an office in Norwood
Norwood, US (HQ)
103 100 River Ridge Dr
Show all (1)
Report incorrect company information

Corbus Pharmaceuticals Financials and Metrics

Corbus Pharmaceuticals Financials

Market capitalization (2-Mar-2018)

349.3 m
Corbus Pharmaceuticals's current market capitalization is $349.3 m.
Show all financial metrics
Report incorrect company information